Interpretation Guide: Broad Spectrum Urine Toxicology Screen
Interpretation Guide: Broad Spectrum Urine Toxicology Screen
January 2016
The Broad Spectrum Urine Toxicology Screen provided by Dynacare incorporates liquid chromatography and tandem mass spectrometry (LC-MS/MS) for the targeted identification of sixty-three (63) different drugs, drug metabolites and preparation ingredients. All urine specimens undergo enzymatic hydrolysis prior to testing, to yield additional free/unconjugated drug and thereby improve detection.
We note that the ability to detect any drug or metabolite in urine is dependent on many factors, including: the dose ingested the analytical method used the positive/negative cut-off concentration selected the individual's metabolic variability - genetic factors, age, gender, etc. the individual's physical condition ? most notably kidney and liver disease the amount of fluid ingested the method and frequency of dosing the time the drug was ingested relative to the time the urine sample was collected
Dynacare Broad Spectrum Urine Toxicology screen is targeted for the specific drug, drug metabolite and preparation ingredients listed below. It will not identify every licit and/or illicit drug that might be in a urine sample. If the drug of interest is not listed in the table below it will not be detected by this screen, at this time.
If a listed analyte was detected in the urine and its concentration exceeded its defined positive/negative cut-off concentration, the specimen will be reported positive for that specific analyte.
A positive result indicates that the analyte is present in the patient's urine at a minimum concentration above its defined screening threshold. A positive result does not indicate the analytes route of administration, ingested dose, concentration in the urine or the patient's level of intoxication.
A negative result may not necessarily mean that the urine is drug free. Negative results can obtained when the drug is present in the urine, but at a concentration that is below the positive/negative cut-off threshold. Negative results may also be obtained if the specific analyte of interest is not included in Dynacare Broad Spectrum Urine Toxicology screen.
We suggest you review the Ontario Association of Medical Laboratories (OAML) guideline entitled "Guidelines for Ordering Urine Testing for Drugs-of-Abuse: Targeted and Screening Tests (CLP013)", found at . Contact Dynacare if additional information is required.
Drug, Drug Metabolite or Preparation Ingredient
Anesthetic Ketamine Anticonvulsant Gabapentin Antidepressants Bupropion mCPP Benzodiazepines
Alprazolam -hydroxyalprazolam
Clonazepam 7-Aminoclonazepam
Diazepam Nordiazepam
Flunitrazepam 7-Aminoflunitrazepam
Flurazepam Desalkylflurazepam
Lorazepam Nitrazepam
7-Aminonitrazepam Oxazepam Phenazepam
Interpretation Guide: Broad Spectrum Urine Toxicology Screen
Common Trade Names
Interpretive Notes
Positive/ Negative Cut-off (ng/mL)
Urine Detection Time
Ketalar
Ketamine detected after use
100 ng/mL
Neurontin
Gabapentin detected after use
500 ng/mL
Wellbutrin, Zyban
Bupropion detected after use Trazodone metabolite; designer drug
250 ng/mL 250 ng/mL
Apo-Alpraz, Xanax
Clonapam Diastat, Diazemuls, Valium Rohypnol
Dalmane, SOM-PAM Ativan Mogadon
Novoxapam, Oxpam
Metabolized to alpha-hydroxyalprazolam; both may be detected after use Alprazolam metabolite Metabolized to 7-aminoclonazepam; metabolite primarily detected after use Clonazepam metabolite Metabolized to nordiazepam, temazepam and oxazepam; all may be detected after use Diazepam metabolite Metabolized to 7-aminoflunitrazepam; metabolite primarily detected after use Flunitrazepam metabolite Metabolized to desalkylflurazepam; metabolite primarily detected after use Flurazepam metabolite Lorazepam detected after use Metabolized to 7-aminonitrazepam; both may be detected after use Nitrazepam metabolite Oxazepam detected after use; nordiazepam and temazepam metabolite Phenazepam detected after use
100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL
2-4 days 2-4 days 2-7 days 1-4 days 1-2 days 5-7 days 1-4 days 2-7 days
Interpretation Guide: Broad Spectrum Urine Toxicology Screen
Drug, Drug Metabolite or
Common Trade Names
Interpretive Notes
Preparation Ingredient
Temazepam
Restoril
Metabolized to oxazepam; both may be detect after use; diazepam metabolite
Triazolam
Triazolam detected after use
Cannabinoids
THCA
Cannabinoid metabolite
JWH-200
Synthetic Cannabinoid
JWH-018
Synthetic Cannabinoid
Opioids and Related Drug Preparation Ingredients
Buprenorphine Norbuprenorphine
Buprenorphine/ Naloxone, Butrans, Suboxone
Metabolized to norbuprenorphine; both may be detected after use; Suboxone and Buprenorphine/Naloxone preparations also include naloxone Buprenorphine metabolite
Tylenol with Codeine
Codeine
No. 2, No. 3 and No. 4; included in many other preparations
Metabolized to norcodeine, morphine and hydrocodone; all may be detected after use
Norcodeine
Codeine metabolite
Fentanyl
Abstral, Duragesic Mat, Metabolized to norfentanyl; both may be detected
Fentanyl Patch
after use
Norfentanyl
Fentanyl metabolite
Heroin 6-Acetylmorphine
Metabolized to 6-acetylmorphine, metabolite primarily detected after use Heroin metabolite
Hydrocodone
Hydrocan, Novahistex DH, Novahistine DH, Tussionex
Metabolized to norhydrocodone, dihydrocodeine and hydromorphone; all may be detected after use; codeine metabolite
Norhydrocodone
Hydrocodone metabolite
Dihydrocodeine
Hydrocodone metabolite
Hydromorphone
Dilaudid, Hydromorph Contin, Jurnista
Hydromorphone detected after use; hydrocodone and morphine metabolite
Positive/ Negative Cut-off 100 ng/mL 100 ng/mL
40 ng/mL 40 ng/mL 20 ng/mL
15 ng/mL
15 ng/mL
100 ng/mL
100 ng/mL 25 ng/mL 25 ng/mL
10 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL 100 ng/mL
Urine Detection Time
1-4 days 1-45 days
2-3 days 1-3 days ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- ordering and interpreting urine drug tests
- how to correctly interpret a urine drug screen result
- interpretation guide broad spectrum urine toxicology screen
- false positive and false negative test results in clinical urine drug
- false positive and false negative results in urine drug screening
- interpretation of opiate urine drug screens
- the opioid epidemic importance of toxicology testing
- urine toxicology use and interpretation kara lynch read only
- false positive interferences of common urine drug quality
- failure of amoxicillin to produce false positive urine screens for
Related searches
- urine drug screen detection windows
- methylphenidate urine drug screen results
- urine drug screen protocol
- urine drug screen interpretation
- urine drug screen methamphetamine positive
- false positive urine drug screen for methamphetamines
- urine drug screen detection period
- urine drug screen thc levels
- urine drug screen metabolite pdf
- urine drug screen opiates
- cpt code for urine drug screen 2019
- urine drug screen cpt code